USANA Health Sciences Files 8-K on Financials
Ticker: USNA · Form: 8-K · Filed: Oct 9, 2025 · CIK: 896264
| Field | Detail |
|---|---|
| Company | Usana Health Sciences Inc (USNA) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, disclosure
Related Tickers: USNA
TL;DR
USANA filed an 8-K on Oct 9, 2025, detailing financial results and operations.
AI Summary
USANA Health Sciences, Inc. filed an 8-K on October 9, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Utah and its principal executive offices are located in Salt Lake City.
Why It Matters
This 8-K filing provides investors with crucial updates on USANA Health Sciences' financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- USANA HEALTH SCIENCES, INC. (company) — Registrant
- October 9, 2025 (date) — Date of Report
- Utah (location) — State of Incorporation
- Salt Lake City (location) — Principal Executive Offices
- 801-954-7100 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on USANA Health Sciences, Inc.'s results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on October 9, 2025.
In which state is USANA Health Sciences, Inc. incorporated?
USANA Health Sciences, Inc. is incorporated in Utah.
What is the address of USANA Health Sciences, Inc.'s principal executive offices?
The address of USANA Health Sciences, Inc.'s principal executive offices is 3838 West Parkway Boulevard, Salt Lake City, Utah 84120.
What is the telephone number for USANA Health Sciences, Inc.?
The telephone number for USANA Health Sciences, Inc. is (801) 954-7100.
Filing Stats: 566 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-10-09 16:10:36
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share USNA New York Stock
Filing Documents
- usna-20251009.htm (8-K) — 25KB
- exhibit991q32025earningsan.htm (EX-99.1) — 75KB
- usanacorplogoresizeda.jpg (GRAPHIC) — 9KB
- 0000896264-25-000210.txt ( ) — 235KB
- usna-20251009.xsd (EX-101.SCH) — 2KB
- usna-20251009_lab.xml (EX-101.LAB) — 21KB
- usna-20251009_pre.xml (EX-101.PRE) — 12KB
- usna-20251009_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On October 9, 2025, USANA Health Sciences, Inc. (the "Company" or "USANA") issued a press release announcing preliminary financial results for the third quarter ended September 27, 2025. The information in this Current Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. The furnishing of the information in this Current Report is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information this Current Report contains is material investor information that is not otherwise publicly available.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure The information disclosed above under Item 2.02, as well as the exhibits attached under Item 9.01 below are incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by USANA Health Sciences, Inc. dated October 9 , 2025 (furnished herewith). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. USANA HEALTH SCIENCES, INC. By: /s/ G. Douglas Hekking G. Douglas Hekking, Chief Financial Officer Date: October 9, 2025